vs
Amarin Corp plc（AMRN）与HomeTrust Bancshares, Inc.（HTB）财务数据对比。点击上方公司名可切换其他公司
HomeTrust Bancshares, Inc.的季度营收约是Amarin Corp plc的1.2倍（$53.6M vs $45.1M），Amarin Corp plc同比增速更快（7.0% vs 3.7%），过去两年HomeTrust Bancshares, Inc.的营收复合增速更高（3.5% vs -18.3%）
Amarin是一家1993年成立的爱裔美籍生物制药企业，总部分别设于爱尔兰都柏林与美国新泽西州布里奇沃特。该企业专注研发及销售心血管疾病治疗药物，已推出处方级Omega-3脂肪酸药物Vascepa（AMR-101）。
HomeTrust Bancshares, Inc.是总部位于美国北卡罗来纳州阿什维尔的银行控股公司，总资产达43亿美元，在北卡、南卡、佐治亚和田纳西州共设有33家网点，旗下拥有HomeTrust银行、Tryon联邦银行等七家社区银行。
AMRN vs HTB — 直观对比
营收规模更大
HTB
是对方的1.2倍
$45.1M
营收增速更快
AMRN
高出3.3%
3.7%
两年增速更快
HTB
近两年复合增速
-18.3%
损益表 — Q1 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $45.1M | $53.6M |
| 净利润 | $-10.5M | — |
| 毛利率 | — | — |
| 营业利润率 | 35.5% | 37.0% |
| 净利率 | -23.3% | — |
| 营收同比 | 7.0% | 3.7% |
| 净利润同比 | 33.0% | — |
| 每股收益（稀释后） | — | $0.93 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收AMRNHTB
| Q1 26 | $45.1M | — | ||
| Q4 25 | $49.2M | $53.6M | ||
| Q3 25 | $49.7M | $54.1M | ||
| Q2 25 | $72.7M | $54.4M | ||
| Q1 25 | $42.0M | $50.9M | ||
| Q4 24 | $62.3M | $51.7M | ||
| Q3 24 | $42.3M | $50.6M | ||
| Q2 24 | $67.5M | $50.6M |
净利润AMRNHTB
| Q1 26 | $-10.5M | — | ||
| Q4 25 | $-1.2M | — | ||
| Q3 25 | $-7.7M | $16.5M | ||
| Q2 25 | $-14.1M | $17.2M | ||
| Q1 25 | $-15.7M | $14.5M | ||
| Q4 24 | $-48.6M | — | ||
| Q3 24 | $-25.1M | $13.1M | ||
| Q2 24 | $1.5M | $12.4M |
毛利率AMRNHTB
| Q1 26 | — | — | ||
| Q4 25 | 47.1% | — | ||
| Q3 25 | 44.7% | — | ||
| Q2 25 | 69.2% | — | ||
| Q1 25 | 59.8% | — | ||
| Q4 24 | -15.4% | — | ||
| Q3 24 | 38.5% | — | ||
| Q2 24 | 63.4% | — |
营业利润率AMRNHTB
| Q1 26 | 35.5% | — | ||
| Q4 25 | -12.9% | 37.0% | ||
| Q3 25 | -22.4% | 38.5% | ||
| Q2 25 | -22.0% | 40.1% | ||
| Q1 25 | -39.9% | 36.2% | ||
| Q4 24 | -84.3% | 35.4% | ||
| Q3 24 | -59.5% | 33.2% | ||
| Q2 24 | -0.8% | 31.3% |
净利率AMRNHTB
| Q1 26 | -23.3% | — | ||
| Q4 25 | -2.5% | — | ||
| Q3 25 | -15.6% | 30.5% | ||
| Q2 25 | -19.4% | 31.6% | ||
| Q1 25 | -37.4% | 28.5% | ||
| Q4 24 | -78.0% | — | ||
| Q3 24 | -59.4% | 25.9% | ||
| Q2 24 | 2.3% | 24.6% |
每股收益（稀释后）AMRNHTB
| Q1 26 | — | — | ||
| Q4 25 | $0.00 | $0.93 | ||
| Q3 25 | $-0.02 | $0.95 | ||
| Q2 25 | $-0.03 | $1.00 | ||
| Q1 25 | $-0.04 | $0.84 | ||
| Q4 24 | $-0.12 | $0.83 | ||
| Q3 24 | $-0.06 | $0.76 | ||
| Q2 24 | $0.00 | $0.73 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $307.8M | $324.7M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | — | $600.7M |
| 总资产 | $645.8M | $4.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资AMRNHTB
| Q1 26 | $307.8M | — | ||
| Q4 25 | $302.6M | $324.7M | ||
| Q3 25 | $286.6M | $315.8M | ||
| Q2 25 | $298.7M | $297.2M | ||
| Q1 25 | $281.8M | $299.8M | ||
| Q4 24 | $294.2M | $279.2M | ||
| Q3 24 | $305.7M | $293.5M | ||
| Q2 24 | $306.7M | $294.2M |
股东权益AMRNHTB
| Q1 26 | — | — | ||
| Q4 25 | $459.3M | $600.7M | ||
| Q3 25 | $458.9M | $595.8M | ||
| Q2 25 | $464.9M | $579.3M | ||
| Q1 25 | $473.7M | $565.4M | ||
| Q4 24 | $486.2M | $551.8M | ||
| Q3 24 | $531.4M | $540.0M | ||
| Q2 24 | $551.9M | $523.6M |
总资产AMRNHTB
| Q1 26 | $645.8M | — | ||
| Q4 25 | $670.8M | $4.5B | ||
| Q3 25 | $659.8M | $4.6B | ||
| Q2 25 | $670.1M | $4.6B | ||
| Q1 25 | $655.7M | $4.6B | ||
| Q4 24 | $685.3M | $4.6B | ||
| Q3 24 | $750.6M | $4.6B | ||
| Q2 24 | $799.9M | $4.7B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | — | $49.5M |
| 自由现金流经营现金流 - 资本支出 | — | $45.3M |
| 自由现金流率自由现金流/营收 | — | 84.5% |
| 资本支出强度资本支出/营收 | — | 7.8% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | $93.8M |
8季度趋势，按日历期对齐
经营现金流AMRNHTB
| Q1 26 | — | — | ||
| Q4 25 | $15.3M | $49.5M | ||
| Q3 25 | $-12.7M | $-11.3M | ||
| Q2 25 | $16.6M | $-8.8M | ||
| Q1 25 | $-12.5M | $71.7M | ||
| Q4 24 | $-13.3M | $45.4M | ||
| Q3 24 | $-2.4M | $43.8M | ||
| Q2 24 | $-2.7M | $5.9M |
自由现金流AMRNHTB
| Q1 26 | — | — | ||
| Q4 25 | — | $45.3M | ||
| Q3 25 | — | $-12.0M | ||
| Q2 25 | — | $-10.2M | ||
| Q1 25 | — | $70.7M | ||
| Q4 24 | — | $42.4M | ||
| Q3 24 | — | $43.1M | ||
| Q2 24 | — | $5.7M |
自由现金流率AMRNHTB
| Q1 26 | — | — | ||
| Q4 25 | — | 84.5% | ||
| Q3 25 | — | -22.2% | ||
| Q2 25 | — | -18.7% | ||
| Q1 25 | — | 138.7% | ||
| Q4 24 | — | 82.0% | ||
| Q3 24 | — | 85.1% | ||
| Q2 24 | — | 11.2% |
资本支出强度AMRNHTB
| Q1 26 | — | — | ||
| Q4 25 | — | 7.8% | ||
| Q3 25 | — | 1.4% | ||
| Q2 25 | — | 2.5% | ||
| Q1 25 | — | 2.0% | ||
| Q4 24 | — | 5.9% | ||
| Q3 24 | — | 1.3% | ||
| Q2 24 | — | 0.5% |
现金转化率AMRNHTB
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | -0.68× | ||
| Q2 25 | — | -0.51× | ||
| Q1 25 | — | 4.93× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.34× | ||
| Q2 24 | -1.81× | 0.48× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
AMRN
| U.S | $35.6M | 79% |
| Europe | $4.9M | 11% |
| Rest-of-World (ROW) | $2.8M | 6% |
| Licensing & Royalties | $1.8M | 4% |
HTB
暂无分部数据
